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Abstract
Background: Internet-sourced drugs are often considered suspect. The World Health Organization reports that drugs from
websites that conceal their physical address are counterfeit in over 50 percent of cases; the U.S. Food and Drug
Administration (FDA) works with the National Association of Boards of Pharmacy (NABP) to regularly update a list of
websites likely to sell drugs that are illegal or of questionable quality.
Methods and Findings: This study examines drug purchasing over the Internet, by comparing the sales of five popular
drugs from a selection of websites stratified by NABP or other ratings. The drugs were assessed for price, conditions of
purchase, and basic quality. Prices and conditions of purchase varied widely. Some websites advertised single pills while
others only permitted the purchase of large quantities. Not all websites delivered the exact drugs ordered, some delivered
no drugs at all; many websites shipped from multiple international locations, and from locations that were different from
those advertised on the websites. All drug samples were tested against approved U.S. brand formulations using Raman
spectrometry. Many (17) websites substituted drugs, often in different formulations from the brands requested. These
drugs, some of which were probably generics or perhaps non-bioequivalent copy versions, could not be assessed
accurately. Of those drugs that could be assessed, none failed from ‘‘approved’’, ‘‘legally compliant’’ or ‘‘not recommended’’
websites (0 out of 86), whereas 8.6% (3 out of 35) failed from ‘‘highly not recommended’’ and unidentifiable websites.
Conclusions: Of those drugs that could be assessed, all except ViagraH passed spectrometry testing. Of those that failed, few
could be identified either by a country of manufacture listed on the packaging, or by the physical location of the website
pharmacy. If confirmed by future studies on other drug samples, then U.S. consumers should be able to reduce their risk by
relying on credentialing agencies recommended lists and by using common sense when examining packaging and pills.
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Introduction
Spending for prescription drugs in the United States hit $216.7
billion in 2006, more than triple the $40.3 billion spent in 1990
[1]. While the lion’s share is still spent in large chain stores like
CVS Caremark or RiteAid, consumers, some probably uninsured,
on a quest for cheaper drugs or drugs off-prescription are
embracing alternative distribution channels–and are increasingly
buying over the Internet [2,3].
In 2009, 30 percent of prescription drug users reported buying
drugs online or through the mail in the previous 12 months, a 9
percent increase over the number who said so in 2008, according
to the Deloitte Center for Health Solutions [4]. Reluctant to
acknowledge purchasing so-called ‘‘lifestyle’’ drugs like painkillers
or those used to treat erectile dysfunction or depression—among
the most popular drugs sold over the Internet—consumers may
underreport their online purchasing behavior. U.S. fraud
prevention and brand protection firm Mark Monitor estimates
the total size of the online market at $12 billion [5].
Website pharmacies are diverse. They include licensed U.S.
pharmacies accredited by the National Association of Boards of
Pharmacy (NABP), and licensed foreign pharmacies approved by the
private credentialing group PharmacyChecker.com, as well as outfits
based in undisclosed international locations, willing to illegally divert
and distribute drugs without a prescription. Non-credentialed website
pharmacies often sell drugs after consumers complete a brief medical
questionnaire, allegedly reviewed by a physician at the website
pharmacy without requiring a prescription, whereas licensed
pharmacies always require a prescription from a physician.
Until recently, much of the academic literature focused on
understanding which drugs—brand and generic—Americans
could buy over the Internet, under what conditions—on or off-
prescription—and at what prices. The quality of drugs available
on the Internet was a secondary consideration, if it was considered
at all [6]. With incidents of poor drug quality widely reported in
the media, and with policymakers considering legislation that
would allow Americans to buy drugs directly from Canada,
researchers have begun to shift their focus.
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including, as the FDA acknowledges, a ‘‘convenient, private, way
to obtain needed medications, sometimes at more affordable
prices.’’ The elderly, infirm, or geographically isolated may be able
to obtain prescriptions more quickly and easily. But drugs
purchased from unverified website pharmacies without a valid
prescription can be dangerous.
According to a 2004 Wall Street Journal/Harris Interactive
poll, most Americans (61 percent) think online drug purchasing
can be dangerous, but nearly one-in-four (23 percent) say they
‘‘aren’t sure’’ whether drugs purchased online are more or less
dangerous than drugs purchased through traditional pharmacies
[7]. Even though federal law technically prohibits the importation
of drugs from overseas except under special circumstances, 4% of
prescription drug users in the United States said in 2009 that they
bought from a foreign source, and 20% of all consumers said
they would likely buy from a source outside the United States if
they could save 50% or more in price [4].
The authors aimed to assess the quality of prescription drugs
that could be purchased over the Internet, and under what
conditions. In order to compare the quality of drugs procured
from websites subject to different levels of regulatory supervision,
the authors intended to stratify the sample into four groups:
‘‘approved,’’ ‘‘legally compliant,’’ ‘‘not recommended,’’ and
‘‘highly not recommended’’ (See Appendix S1).
Materials and Methods
The authors identified drugs most likely to be purchased by
American consumers in several drug classes by cross-tabulating
consumer self-reports [7] with industry data, including lists of the
most-popular online drug searches from licit website pharmacies
and IMS’s list of the top 10 products ‘‘most often prescribed’’ in
the United States in 2007. The five drugs selected for purchase
were (in order of selection priority):
LipitorH 10mg (atorvastatin calcium) a synthetic lipid-lowering
agent to reduce cholesterol, manufactured by Pfizer Inc.
ViagraH 100mg (sildenafil citrate) an oral therapy for erectile
dysfunction, manufactured by Pfizer Inc.
CelebrexH 200mg (celecoxib) a nonsteroidal anti-inflammatory
drug for treatment of arthritis, manufactured by Pfizer Inc.
NexiumH 40mg (esomeprazole magnesium) a proton pump
inhibitor for treatment of Gastroesophageal Reflux Disease,
manufactured by AstraZeneca Pharmaceuticals LP
ZoloftH 100mg (sertraline HCl) a selective serotonin reuptake
inhibitorfor treatmentof depression,manufacturedby PfizerInc.
The dosages chosen were the most popular among identified
websites and after consultation with Joseph Moody, MD, the
physician advising this study. With the approval of his state health
board, Dr. Moody provided prescriptions for the drugs. The
prescriptions were for the established dosages but in varying
quantities. A uniform homogeneous database of samples from
website pharmacies was not possible since many websites only sell
in prohibitively large (and expensive) quantities, do not sell all five
brand-name versions of the drugs, or do not sell the drugs in the
required dosages. While only ZoloftH is no longer under patent in
the United States, websites sourcing drugs from overseas may try
to supply generic or copy versions of the other drugs, which may
be legally produced for domestic consumption in other parts of the
world (although illegal if sold in the United States). During the
procurement process, the authors always instructed website
pharmacies to provide brand-name drugs, and did not procure
from websites where only generic versions were available.
Once the most popular dosages were identified, reference
standards were established for the chosen handheld Raman
spectrometer. The spectrometer created a detailed spectral
‘‘fingerprint’’ for each reference standard, which was then
compared against spectral readings from drugs procured over
the Internet. To create the reference standards, genuine samples
provided via prescription by a national pharmacy chain (West
Lafayette, IN, USA) were analyzed using the Raman spectrometer
and cross-checked against a second lot from a separate pharmacy
to verify consistency and determine method robustness. In cases
where it appeared slight lot-to-lot variation was present (as in the
case for LipitorH coating thickness), a reference spectrum from
both lots was included in the Raman spectroscopic method. In all
cases, the two lots of drugs matched well and it was deemed that
they were representative samples of authentic products.
Drugs were ordered in January, February, and then again in
September 2009 from website pharmacies identified using Google
and Yahoo! search criteria and the NABP list of approved and not
recommended websites (See Appendix S1), as well as examination
of spam emails sent to the authors and those caught in the spam
filters of their organizations. Attempts to purchase from some
websites were unsuccessful. Two website pharmacies from the
NABP-approved list returned prescriptions; three websites from
the not recommended list would not accept payment; and in two
cases, ordered drugs from highly not recommended websites were
never received. While every reasonable effort was made to procure
drugs from each website, this was not always possible. The lead
author attempted to procure drugs from websites experiencing
problems three times before moving on to the next website.
Fourteen of the drug packages received could not be linked
directly to a website because multiple purchases were ‘active’ at
the same time, and the packaging was not identifiable. The
purchases were not made in a linear fashion – ordering from one
website and not ordering from the next until the first was received.
The authors assessed drug quality using Raman spectrometry.
Numerous studies have demonstrated that Raman spectrometry is
a quick, reliable and cost-effective way for non-specialists to
differentiate between genuine and counterfeit drugs [8–11]. To
ascertain the nature, and not just the spectra, of all compounds in
a given drug, including impurities and degradation products as
well as active ingredients, high-performance liquid chromatogra-
phy (HPLC), considered the current gold standard analytical
method in drug analysis, would be required. HPLC requires
sophisticated sample preparation that is expensive and time
consuming and requires trained chemists for analysis and
interpretation of results. Given that the aim of this study was to
authenticate a finished product (rather than its individual
components), comparison with a known HPLC standard was
unnecessary. The authors used a handheld Raman spectrometer,
the TruScan by Ahura Scientific (Wilmington, MA), on loan for
the duration of the study. One necessity, and potential limitation,
of spectrometers is that they require exact reference standards,
obtained by scanning each separate brand with the same
formulation for calibration. This means that a drug substituted
for the branded version would record likely as a failure (since the
excipients could be different, yielding different spectra, between
two equally effective drugs). For this reason, generic substitutes
were not sought from websites for this study.
Whilea passidentifies a good qualitydrug,a ‘‘failure,’’asassessed
by the authors, does not mean that a given drug is necessarily of low
quality. The spectrometer recorded a ‘‘failure’’ if a sampled drug
was spectroscopically inconsistent with the reference standard;
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bioequivalent generics of the chosen drugs may fail, because while
they must contain the same quantities of active ingredient, they
often contain different binding agents (excipients) in different
concentrations. The spectrum created by the spectrometer is for the
total sample formulation, not only the active ingredient.
Four samples from each drug from each website pharmacy were
tested; additional samples were tested when there were failures,
with the more positive results being recorded. Five websites only
sent three tablets of ViagraH each, all of which were tested.
In order to compare prices of drugs with the same formulations,
purchased in the same quantities, the authors identified prices
posted on the website or quoted by a pharmacy representative
over the phone in early May 2009. If the formulation was not
available in the same quantity, the authors selected the closest
quantity available. Prices were calculated as ‘‘stand-alone’’ orders;
that is, shipping expenses were not amortized across the entire
five-drug order. The authors also identified prices of the five drugs
sold at physical-location pharmacies in the Washington, D.C.
area. Six pharmacies were selected as the closest within a 0.5 mile
radius of the lead author’s home address using Google Maps. No
more than one of each chain pharmacy was selected.
Results
The authors received drugs from 55 website pharmacies, among
them six ‘‘approved,’’ ten ‘‘legally compliant,’’ ten ‘‘not recommend-
ed,’’ fifteen ‘‘highly not recommended,’’ and fourteen that were ‘‘not
recommended’’ or ‘‘highly not recommended’’ but could not be
identified by name because the packaging provided could not be
perfectly matched with the pre-orders. A total of 152 drug orders were
received, including 25 CelebrexH,2 5L i p i t o r H,2 2N e x i u m H,5 0
ViagraH, 28 ZoloftH and two unknowns from two unidentifiable
websites. Of these, samples from 121 drug orders were tested using
Raman spectrometry. NexiumH tablets from eleven websites and
ZoloftH capsules from five websites could not be assessed because the
authors’spectrometry protocolwasestablished withreference standards
for NexiumHcapsules and ZoloftHtablets (the typical drug formulations
sold in the United States). Additionally, one order of ‘‘sertraline HCl’’
tablets and three orders of ‘‘DaxidH’’ tablets were received in place of
ZoloftH a n dc o u l dn o tb ea s s e s s e ds i n c er e f e r e n c es t a n d a r d sw e r en o t
available. Lastly, blue tablets shaped like ViagraH,w h i c hw e r en o t
labeled ‘‘ViagraH’’ and not labeled as being manufactured by Pfizer,
were received from three ‘‘highly not recommended’’ websites and six
unidentifiable websites; they were notassessedinthe main analysissince
their identity could not be confirmed (these samples are included in the
50 ViagraH drug orders received above, and are included in Figure 1
for price and quality of ViagraH and its copies). Two unknown drugs
accompanied two of the suspected ViagraH orders (it was presumed
that these unknowns were copies of the erectile dysfunction drug
CialisH, given their shape, size and coloring) and were not assessed since
their identity could not be confirmed.
Seventy samples were tested from January to April 2009, and 51
samples were tested in April 2010. 2.5% (3/121) of tested samples
failed Raman spectrometry: 0% of CelebrexH (0/25), 0% of
LipitorH (0/25), 0% of NexiumH (0/11), 7.3% of ViagraH (3/41),
and 0% of ZoloftH (0/19) (See Table 1).
Only brand-name drugs were ordered in this study; however, 15
website pharmacies failed to comply with instructions and sent
copy versions in place of the brand-name drug. The authors did
not attempt to verify the authenticity or quality of these substitutes
since reference standards were not available. Previous attempts to
obtain samples from various companies were only partly
successful; the authors were concerned that reference samples
would not be received from all companies in a timely manner,
potentially biasing results. It is possible that drug substitution may
have occurred unbeknownst to the authors, i.e. the drugs were not
labeled as such, and as a result they may have failed testing due to
different excipients as explained above.
Of the website pharmacies accredited by NABP, only one
provided a drug which was not in testable form; in this case, the
bottle was labeled ‘‘Sertraline HCl 100mg.’’
Eight ‘‘legally compliant,’’ ‘‘not recommended,’’ or ‘‘highly not
recommended’’ website pharmacies sent NexiumH tablets instead of
capsules, allegedly produced for AstraZeneca in Turkey (5 orders),
Canada (2 orders), and Sweden (1 order). By comparing the Raman
spectra of the NexiumH tablets against the spectra of the NexiumH
capsules, the authors determined that all of the NexiumH tablets
Figure 1. ViagraH and its copies by price in US$ (including 14 samples of suspected ViagraH whose identity could not be confirmed).
‘‘Copy Viagra with API’’ refers to samples which are copies of ViagraH (it was not established whether they were bioequivalent copies - generics) and,
from spectrographic analysis, which contain the correct active pharmaceutical ingredient (API) – sildenafil citrate. ‘‘Copy Viagra with Zero API’’ refers
to samples which are copies of ViagraH that do not contain any sildenafil citrate.
doi:10.1371/journal.pone.0012199.g001
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from two of the NexiumH tablet orders with AstraZeneca’s Global
Quality Operations identified the tablets and their batch numbers as
consistent with genuine product packaged for AstraZeneca in Turkey.
Three orders of tablets labeled ‘‘NeksiumH’’ instead of NexiumH
were received from ‘‘legally compliant’’ or ‘‘not recommended’’
website pharmacies. They were allegedly manufactured by a
company for AstraZeneca India in Bangalore. The tested samples
had spectra unlike the NexiumH capsules or NexiumH tablets, and
did not appear to contain the main NexiumH active ingredient,
esomeprazole. A high level of fluorescence was associated with the
individual spectra of these tablets which precluded the automated
analysis. The packaging indicated that NeksiumH is ‘‘For Sale in
India and Nepal Only.’’ One website pharmacy attempted to cover
up this text by placing a sticker ‘‘To be dispensed against doctor’s
prescription only’’ on top of it. The authors informed AstraZeneca
about this potentially counterfeited drug and, as a result,
AstraZeneca launched an internal investigation. After careful
consideration of samples from two of the NeksiumH orders, a
report was returned to the authors indicating the tablets and their
batch numbers were consistent with product manufactured and
packaged for AstraZeneca India by a third party contractor.
Three ‘‘legally compliant’’ or ‘‘not recommended’’ website
pharmacies sent ‘‘DaxidH’’ tablets in place of ZoloftH tablets,
which were not in testable form but passed spectrometry testing
when tested against the ZoloftH reference standard. The packaging
indicated that DaxidH is ‘‘For Sale in India Only’’ and is
manufactured by Pfizer Limited in India. All website pharmacies
Table 1. Spectrometry testing results by drug type and website pharmacy classification.
Website classification Number received Number in testable form Percent that failed testing
LipitorH NABP approved
i 66 0 %
Legally compliant
ii 10 10 0%
Not recommended
iii 55 0 %
Highly not recommended
iv 44 0 %
Combined Total 25 25 0%
ViagraH NABP approved 6 6 0%
Legally compliant 10 10 0%
Not recommended 5 5 0%
Highly not recommended 15 12 8.3% (1/12)
Unidentifiable 14 8 25% (2/8)
Combined Total 50 41 7.3% (3/41)
CelebrexH NABP approved 6 6 0%
Legally compliant 10 10 0%
Not recommended 5 5 0%
Highly not recommended 4 4 0%
Combined Total 25 25 0%
NexiumH NABP approved 6 6 0%
Legally compliant 10 3 0%
Not recommended 2 0
Highly not recommended 4 2 0%
Combined Total 22 11 0%
ZoloftH NABP approved 6 5 0%
Legally compliant 9 6 0%
Not recommended 6 3 0%
Highly not recommended 7 5 0%
Combined Total 28 19 0%
Unknown Unidentifiable 2 0
TOTAL NABP approved 30 29 0%
Legally compliant 49 39 0%
Not recommended 23 18 0%
Highly not recommended 34 27 3.7% (1/27)
Unidentifiable 16 8 25% (2/8)
Combined Total 152 121 2.5% (3/121)
i‘‘Approved’’: have been accredited by the U.S. NABP.
ii‘‘Legally compliant’’: have not been accredited by NABP, but nor are they listed on NABP’s ‘‘not recommended’’ list. PharmacyChecker, an independent group not
affiliated with any given pharmacy, indicates that they are in compliance with the laws in the country in which they are registered.
iii‘‘Not recommended’’: approved by PharmacyChecker, but ‘‘not recommended’’ by NABP.
iv‘‘Highly not recommended’’: ‘‘not recommended’’ by NABP and unlisted or ‘‘not approved’’ by PharmacyChecker.
doi:10.1371/journal.pone.0012199.t001
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one that read ‘‘To be dispensed against doctor’s prescription only’’
on top of it.
Of the 55 website pharmacies sampled, and of those drugs
which could be tested against established reference standards, 0%
(0/29) of drugs from ‘‘approved’’ websites failed, 0% (0/39) of
drugs from ‘‘legally compliant’’ websites failed, 0% (0/18) of drugs
from ‘‘not recommended’’ websites failed, 3.7% (1/27) of drugs
from ‘‘highly not recommended’’ websites failed, and 25% (2/8) of
drugs from websites that were either ‘‘not recommended’’ or
‘‘highly not recommended’’ but could not be identified by name
failed (See Table 1). All drugs purchased from the ‘‘approved’’ and
‘‘legally compliant’’ website pharmacies were accounted for,
whereas the latter classifications had websites which may not
have delivered drugs, or had delivered drugs in unidentifiable
packaging and were not identifiable in other ways.
‘‘Highly not recommended’’ website pharmacies tended to offer
fewer types of drugs than the other website classifications. Of these
websites, only four delivered any of the five drugs other than
ViagraH. In two cases, ViagraH and NexiumH were initially
ordered, but only ViagraH was delivered. In the first instance,
NexiumH was crossed out on the package receipt but the author’s
account was charged for the missing drug, in the second, the
author’s account was charged for the ViagraH but not the
NexiumH.
The authors assessed the country of manufacture, where
possible. Many websites, particularly NABP-approved websites,
like most U.S. retail pharmacies, sent drugs packaged in orange,
cylindrical ‘‘pill pots,’’ which often did not list a country of
manufacture. Of the 152 drug orders received 43% (65) came
from outside of North America and 16% (24) from within North
America (Canada 8, United States 16). The remaining 41% (63)
were of unknown origin or could not be assessed.
Drugs were manufactured in Italy (1.5 samples), Germany (0.5
sample), Australia (6 sample), Australia/New Zealand (21 samples;
both countries were listed on the same package; a phone call to the
pharmacy could not clarify where these drugs were manufactured),
India (12 samples), Sweden (1 sample), Turkey (23 samples),
Canada (8 samples) and the United States (16 samples). For one of
the drug orders, half of the packages received listed Italy as the
country of manufacture and the other half listed Germany. Of the
remaining 63 drug orders, it is likely that many were manufac-
tured in the U.S., given their source (NABP-approved websites),
appearance, and formulations. Some of the drugs with an
unknown country of manufacture, however, likely came from
elsewhere: drugs that were probably copy versions of ViagraH
arrived with postmarks from India, for example.
Half of the samples with packaging that said they were
manufactured in Canada (4 of 8), all of the samples from India
(12 of 12), the single sample from Sweden (1 sample), 13 of the 23
samples from Turkey, and 1 of 16 samples from the United States
were not in testable form. Of the drugs that were in testable form,
only one that listed a country of manufacture (in this case, ViagraH
tablets that were allegedly manufactured in the United States)
failed spectrometry testing.
Problems of Provenance & Packaging
Many drugs, including some that did not fail spectrometry
testing, had worrying irregularities in provenance or packaging.
One website pharmacy claimed to be based in Ontario, Canada,
but the receipts included in the packages stated that the drugs had
been shipped from Australia and India, as well as the United
States. The return addresses on the packages indicated that they
had passed through Vanuatu, Germany, or Santa Ana, California.
Four of the five drugs (with the exception of NeksiumH, which was
not in testable form) purchased from this website pharmacy passed
spectrometry testing.
In12 cases,drugswereshipped from a differentlocation thanwas
indicated on the website. Three claimed to be U.S. or Canada-
based and advertised prices in dollars on their website, yet charged
in Chinese or Indian currency. One website pharmacy described
itself as an ‘‘off-shore company based in Cyprus,’’ but listed a
contact address in British Columbia. The authors were not able to
determine where exactly the funds were deducted from for the
transaction. In reviewing statements from the bank account used in
this study, the initial transfer was sent to Panama, not a known
location for the company. ViagraH ordered from this website
arrived wrapped in aluminum foil, with a postmark from Shanghai.
Labeled as ‘‘Pfizer Inc. USA’’ ViagraH, all four tablets tested failed
Raman spectrometry. The shipping envelope and drug packaging
wassimilar toa reported port securityseizure one oftheauthorshad
seen at a public presentation by a Pfizer security expert.
Eleven website pharmacies shipped international versions of
brand-name drugs. One website pharmacy provided ZoloftH
capsules that were bright orange in a bottle labeled as ‘‘Pfizer
Canada.’’ Another website, based in Vanuatu, shipped CelebrexH,
LipitorH, and ZoloftH marked ‘‘Pfizer Australia’’ – all of which
passed Raman spectrometry testing. Another website pharmacy
claimed to be based in British Columbia, Canada, but the drug
orders arrived with postmarks from the Deutsche Post, with a
Swiss Post Declaration and Customs Authorities Form, and a
Zurich Airport Label. The drugs received were allegedly
manufactured by three separate drug companies. Another website
pharmacy sent an order of loose tablets in a plastic bag with
packaging and information inserts that could not be connected
with any of the initial purchase websites. In this case, the drug
order arrived with a return address for Vienna, Austria. The
tablets were blue in color, shaped like ViagraH and stamped with
‘‘Pfizer’’ - all tested samples failed Raman spectrometry.
The Purchasing Experience
Four website pharmacies could not supply all the drugs they
claimed to offer. One website claimed to have ‘‘sold out’’ of
LipitorH when the authors attempted to procure it. Six websites
were portals to many other websites, many of which crashed after
the lead author submitted the medical questionnaire that
accompanies many websites. When this happened, drugs could
not be procured.
Thirty-seven website pharmacies offered prescription drugs
without requiring an original prescription. All of the NABP-
approved and ‘‘legally compliant’’ websites, except one, either
demanded original prescriptions or (for two websites) accepted
faxed prescriptions but followed-up with the prescribing physician
to establish provenance. These website pharmacies appeared to
focus on building a long-term relationship with the consumer.
Indeed, seven of the 18 websites described by NABP as
‘‘recommended’’ would not even sell prescription drugs to an
individual unless he or she was connected with a medical insurer.
All of the ‘‘not recommended’’ and ‘‘highly not recommended’’
website pharmacies claiming to require prescriptions accepted
faxed or emailed copies without contacting the prescribing
physician to confirm. One website openly advertised the provision
of drugs off prescription. Other website pharmacies offered to
supply drugs after the consumer filled out an online evaluative
questionnaire, which varied in length and complexity. Most of the
‘‘not recommended’’ and ‘‘highly not recommended’’ website
questionnaires were very basic, although five took at least
Website Pharmacy Drug Quality
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conditions and contraindications associated with the drugs.
‘‘Cheap’’ Drug Websites: Buyer Beware?
There was wide price variation among the procured drugs.
Among purchased drugs, which had some variation in formulation
and quantity, ViagraH was, on average and within each website
classification, the most expensive drug, and also the drug with the
greatest range in price. Prices per tablet for ViagraH ranged from
$13.12 to $41.00 per tablet, including shipping expenses and other
expenses (one website charged a processing fee and another
website charged for a pill splitter) amortized across the entire
order. This compared to ranges between $1.14 and $19.40 per
tablet/capsule for NexiumH, $0.91 to $7.07 for LipitorH, $1t o
$4.63 for ZoloftH, and $1.24 to $4.27 for CelebrexH.
In general, larger orders tended to have lower per-tablet/per-
capsule prices, and were more prevalent among website
pharmacies that had not been approved by NABP. In order to
determine whether the difference in price observed was due to
order size, the authors assessed the prices offered for all of the
drugs in consistent formulations (insofar as was possible; not all
websites offered drugs in the same, consistent quantities) (See
Table 2). In this case, orders were considered ‘‘stand-alone’’ and
shipping prices were not amortized across the entire order.
Average prices for NexiumH, LipitorH and ZoloftH at NABP-
approved websites were slightly more expensive than the other
three classifications. The average price of CelebrexH from NABP-
approved websites was more than twice that of the other website
classifications. ViagraH offered from non-credentialed websites,
was on average far more expensive than ViagraH from
credentialed websites. For all of the drugs except ViagraH, prices
were most expensive at physical-location pharmacies (See Table 2).
If sellers of diverted drugs have relatively low transit and
transaction costs, they can profit handsomely. NeksiumH procured
from one website for $83 ($2.96/tablet) included a label on the box
that indicated it could be sold for no more than INR 6.73/tablet in
India (approximately $0.14/tablet depending on the exchange
rate), a mark-up of more than 2000%. For an additional twenty
drugs whose packages included list prices from countries other
than the United States, mark-ups ranged from 236% to more
than 1400% (See Table 3).
Since the only drug samples (in testable form) to fail testing were
fake copies of ViagraH containing zero active pharmaceutical
ingredient (API), the prices of the drugs that failed and those that
passed were analyzed, as well as the prices of those that were
copies of ViagraH, which had active ingredient but would ‘‘fail’’
spectrometry testing.
The results were stark; the fake ViagraH with zero API were the
cheapest, followed by the ViagraH copies containing API, followed
by actual ViagraH, and the differences were all statistically
significant (See Figure 1).
Discussion
Few drugs that could be tested against reference standards,
failed; there was, however, some drug substitution, which limited
the number of samples that could be assessed. In addition,
NexiumH tablets are not approved for sale in the United States,
but are common in Europe and much of the rest of the world.
Since tablets have different excipients and different coatings than
capsules, their spectra are slightly different. As a result, samples
from each of the NexiumH tablet orders failed when tested against
the NexiumH capsule reference standard. Even assuming all
substitutes were bioequivalent copies (i.e. generics), risks remain
for unwary purchasers of drugs over the Internet. Substandard
ViagraH, almost certainly counterfeit, was procured with packag-
ing that indicated the samples originated in China. There have
been reports that many fake pharmaceuticals originate in China
and India [12].
The study findings underscore the difficulty for monitoring
organizations like the NABP and PharmacyChecker.com to keep
their ‘‘recommended’’ and ‘‘not recommended’’ website lists up-
to-date. Internet search engines require all advertisers and their
affiliates who sell prescription drugs to be approved by
PharmacyChecker.com. One website pharmacy appeared to have
changed classification during the course of the study: when drugs
were purchased from the website, it was within the ‘‘legally
compliant’’ classification, listed as approved by PharmacyCheck-
er.com, and was not listed on NABP’s ‘‘not recommended’’ list. It
later appeared on NABP’s ‘‘not recommended’’ list. (In this study,
the website was listed as ‘‘legally compliant’’ to reflect classification
at the time of selection.) All of the drugs from this website passed
spectrometry testing or were not in testable form (NeksiumH).
Website pharmacies can, in principle, shut down and simply re-
open under a new name. For website pharmacies based in foreign
countries, the FDA and Drug Enforcement Agency have little
recourse for action except to appeal to national authorities in these
countries. Encouragingly, evidence suggests that some foreign
Table 2. Average price per tablet/capsule (minimum-maximum) of drugs with as consistent formulations and quantities as
possible (not purchased).
Website Classification
(number of websites*) CelebrexH 200mg690 LipitorH 10mg690 NexiumH 40mg628 ViagraH 100mg64** ZoloftH 100mg6100
NABP approved (6) $3.89 (3.54–4.06) $2.98 (2.71–2.98) $5.74 (5.07–6.20) $17.21 (13.94–20.55) $3.68 (3.12–4.32)
Legally compliant (10) $1.91 (1.33–3.84) $1.72 (1.00–2.89) $3.11 (1.43–5.62) $14.94 (12.38–17.49) $2.11 (1.05–3.53)
Not recommended (10) $1.76 (1.72–1.84) $1.58 (1.09–1.88) $3.08 (2.50–3.75) $20.5 (15.00–36.00) $1.56 (1.08–2.21)
Highly not recommended (15) $1.63 (1.58–1.69) $1.69 (1.61–1.76) $5.56 (2.71–7.03) $23.95 (17.25–33.65) $2.70 (1.60–3.79)
CelebrexH 200mg630 LipitorH 10mg630 NexiumH 40mg630 ViagraH 100mg64 ZoloftH 100mg630
Physical-location pharmacy*** (5) $4.50 (4.00–5.07) $3.44 (3.00–3.87) $6.26 (5.40–6.83) $17.75 (15.58–20.35) $4.36 (4.03–5.03)
*Not all websites offered drugs in the same, consistent quantities.
**There was greater variation in the quantities for ViagraH than for the other drugs. Quantities ranged from 3 tablets to 10 tablets.
***‘‘Physical-location pharmacy’’: Pharmacies were selected as the closest within a 0.5 mile radius of the lead author’s home address (using Google Maps). No more than
one of each chain pharmacy was selected. In addition, the authors included a nearby Wal-Mart store. One pharmacist refused to provide price information.
doi:10.1371/journal.pone.0012199.t002
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when it publicly blacklisted 25 websites for selling and/or
advertising counterfeit and substandard products in March 2009
[13].
The variety of price mark-ups—and some mark-downs—
illustrate a tiny part of the inner-workings of an illicit, global
‘‘parallel’’ trade in pharmaceuticals (although wholesalers are
permitted to sell pharmaceuticals across borders in the European
Union, such practice is illegal in the United States). The presence
of a mark-down at first appears puzzling: why would a seller offer a
pharmaceutical for $1.22 over the Internet when he or she
theoretically could sell it for $1.91 in the European Union? It is
possible that the market in the European Union may have been
‘‘flooded’’ with the product, thereby depressing prices. The
product may have been stolen; by peddling it overseas, the seller
faced less chance of detection; in a market characterized by
government-imposed profit caps, heavy taxes, and other disincen-
tives to sell the product to the highest bidder, wholesalers and/or
pharmacies might well be eager to sell the product overseas.
Of course, legitimate website pharmacists may well have
received drug supplies in large enough amounts to be able to
offer discounted prices, but given small markups and the relatively
competitive market of Europe this is unlikely to be more than a
few percentage points.
While a larger sample size is needed to make broad conclusions,
findings suggest that drugs procured from so-called ‘‘cheap’’
website pharmacies may not always be less expensive than more
reputable websites, or at least in the case of ViagraH, even less
expensive than physical-location pharmacies. Several of the ‘‘not
recommended’’ and ‘‘highly not recommended’’ website pharma-
cies required that consumers purchase drugs in large quantities, or
only permitted consumers to purchase one kind of drug at a time
(each time adding processing and shipping fees), which increased
the overall price even more.
The ease with which the lead author was able to procure drugs
from non-credentialed websites without a prescription or by using
photocopies or faxed versions of prescriptions suggests that there is
ample opportunity for prescription drug abuse. The lead author
was able to procure several drugs from 55 website pharmacies
under the same consumer name over several months. For the
websites that required prescriptions, the lead author was able to
use the same prescriptions more than five times because of the lack
of insistence on original versions (many website pharmacies allow
consumers to fax prescriptions without contacting the prescribing
physician). Not one website pharmacy checked why the lead
author, a resident of Washington D.C., was using a physician in
Indiana for his prescriptions (he has no obvious ties to Indiana and
has never visited the state).
Regulatory agencies or associations such as the NABP or
PharmacyChecker.com might consider establishing an informa-
tion-sharing system among registered pharmacies that would allow
pharmacists to quickly identify whether a prescription for a given
drug has already been dispensed to a given individual. Such
information systems already exist for physicians to track
prescriptions of controlled substances in some states, but are not
widely used [14].
Of course, one of the reasons consumers buy over the Internet is
convenience, and often they know exactly what drugs they require.
There may be frustration in dealing with increased drug delivery
bureaucracy. The authors suggest that the situation established by
the better known websites may be the way forward. A consumer
establishes a profile with a website pharmacy, sends in an original
prescription for each drug, and from then on everything can be
done by email and phone, with the pharmacist dealing directly
Table 3. Diverted drug mark-ups: Price per tablet/capsule.
Drug Received Price US$ Other Price % Mark-Up (difference price/other)
CelebrexH 906200mg $1.22 EU 1.43 (=$1.91) 236%
LipitorH 90610mg $0.89 TRY 1,07 (=$0.67) 33%
LipitorH 30610mg $1.67 TRY 1,07 (=$0.67) 149%
LipitorH 30610mg $1.83 TRY 1,08 (=$0.67) 173%
LipitorH 90610mg $1.22 TRY 1,08 (=$0.67) 82%
LipitorH 90610mg $1.37 TRY 1,08 (=$0.67) 104%
NeksiumH 28640mg $1.07 INR 6.81 (=$0.14) 664%
NexiumH 28640mg $2.68 TRY 2,27 (=$1.45) 85%
NexiumH 28640mg $3.39 TRY 2,27 (=$1.45) 134%
NeksiumH 28640mg $2.96 INR 6.73 (=$0.14) 2014%
NeksiumH 28640mg $2.14 INR 6.81 (=$0.14) 1429%
NexiumH 28640mg $2.37 TRY 2,26 (=$1.45) 63%
NexiumH 28640mg $2.47 TRY 2,26 (=$1.45) 70%
ViagraH 46100mg $15.25 TRY 17,73 (=$11.10) 37%
ViagraH 46100mg $12.50 TRY 18,6 (=$11.89) 5%
ViagraH 86100mg $14.50 TRY 17,73 (=$11.34) 28%
ZoloftH 1126100mg $1.92 EU 1.61 (=$2.16) 211%
ZoloftH 1006100mg $1.45 INR 9.08 (=$0.18) 706%
ZoloftH 1006100mg $0.98 INR 8.67 (=$0.18) 444%
doi:10.1371/journal.pone.0012199.t003
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patient to establish a relationship with the pharmacist to receive
drug counseling and adverse effects monitoring. This provides the
pharmacist and physician assurance that the patient is not abusing
the drugs and is taking them safely, and it is also convenient for the
patient.
Not all consumers—particularly those wishing to bypass the
requirement for a doctor’s prescription, however—will favor such
an option. And no doubt they will shop around for the cheapest
option; for their sake, one hopes they find safe products as well.
Furthermore, many websites seem to price products in ways that
make it more expensive than otherwise would be the case, making
each drug type a separate order with delivery and other charges
built in. Shopping around to avoid this should save money and
over time will probably drive the more expensive sellers from the
market.
Political Discussion and Conclusions
This study demonstrates that there are many website pharma-
cies, including those from overseas, from which it is almost
certainly safe to procure medicines; indeed, all of the pharmacies
approved by both NABP and PharmacyChecker.com passed the
authentication spectrometry tests undertaken in this study.
With changes to U.S. healthcare legislation and the increased
push for drug importation, the debate about drug safety over the
Internet is likely to intensify. The economic and ethical arguments
for market segmentation, preventing wholesale importation, are
strong. But few Americans care about this when they pay the
highest prices globally for drugs. Some interests opposed to
importation therefore claim drug buying over the Internet is
dangerous, obfuscating unlicensed website pharmacies, which pose
a safety threat, with licensed website pharmacies, which probably
sell good quality drugs. If this conclusion is replicated in other
studies for other drugs and in larger sample sizes, then the safety
issue will be clarified and will hopefully dissolve.
Supporting Information
Appendix S1 How website pharmacies were selected.
Found at: doi:10.1371/journal.pone.0012199.s001 (0.03 MB
DOC)
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